U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Daptomycin Injection Products
  1. Development Resources

Daptomycin Injection Products

 

 

Minimum Inhibitory
Concentrations
(mcg/mL)

Disk Diffusion
(zone diameter in mm)

Pathogen

S

I

R

S

I

R

Enterococcus faecalis (including vancomycin-resistant isolates)*

≤2

4

≥8

-

-

-

Staphylococcus aureus (including methicillin-resistant isolates)

M100 standard is recognized

-

-

-

Streptococcus pyogenes

M100 standard is recognized

-

-

-

Streptococcus agalactiae

M100 standard is recognized

-

-

-

Streptococcus dysgalactiae

M100 standard is recognized

-

-

-

S = Susceptible; I = Intermediate; R = Resistant

* Susceptibility test interpretive criteria are based on the daptomycin dose of 4 mg/kg once every 24 hours

Exception to the recognized standard of CLSI M100

For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Enterococcus faecium

 
Back to Top